摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-[2-[4-Chloro-3-[1-[(4-methylanilino)-phenylmethyl]benzimidazol-2-yl]phenyl]ethyl]-2-phenylquinazolin-4-one | 1404067-26-0

中文名称
——
中文别名
——
英文名称
3-[2-[4-Chloro-3-[1-[(4-methylanilino)-phenylmethyl]benzimidazol-2-yl]phenyl]ethyl]-2-phenylquinazolin-4-one
英文别名
——
3-[2-[4-Chloro-3-[1-[(4-methylanilino)-phenylmethyl]benzimidazol-2-yl]phenyl]ethyl]-2-phenylquinazolin-4-one化学式
CAS
1404067-26-0
化学式
C43H34ClN5O
mdl
——
分子量
672.229
InChiKey
BPEOMPWXKUTNAH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    10.1
  • 重原子数:
    50
  • 可旋转键数:
    9
  • 环数:
    8.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    62.5
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    2-phenyl-3-[5-(2-chloro-3-carboxylatophenyl)ethyl]4(3H)-quinazolone 在 吡啶 作用下, 反应 10.0h, 生成 3-[2-[4-Chloro-3-[1-[(4-methylanilino)-phenylmethyl]benzimidazol-2-yl]phenyl]ethyl]-2-phenylquinazolin-4-one
    参考文献:
    名称:
    Novel Benzimidazole Analogs as Inhibitors of EGFR Tyrosine Kinase
    摘要:
    A series of new benzimidazole congeners were synthesized, and their structures were elucidated on the basis of elemental analyses and spectral studies (1H NMR, FT‐IR and EI‐MS). Preliminary pharmacokinetic studies showed a promising outlook for further in vivo evaluation. The newly synthesized compounds were tested in vitro on human breast carcinoma cell line (MCF‐7) in which EGFR is highly expressed. Most of the tested compounds exhibited antitumor activity with IC50 values in the micro to nano molar range.
    DOI:
    10.1111/j.1747-0285.2012.01407.x
点击查看最新优质反应信息

文献信息

  • Novel Benzimidazole Analogs as Inhibitors of EGFR Tyrosine Kinase
    作者:Soni Yadav、Deepa Sinha、Sanjay K. Singh、Vinay K. Singh
    DOI:10.1111/j.1747-0285.2012.01407.x
    日期:2012.10
    A series of new benzimidazole congeners were synthesized, and their structures were elucidated on the basis of elemental analyses and spectral studies (1H NMR, FT‐IR and EI‐MS). Preliminary pharmacokinetic studies showed a promising outlook for further in vivo evaluation. The newly synthesized compounds were tested in vitro on human breast carcinoma cell line (MCF‐7) in which EGFR is highly expressed. Most of the tested compounds exhibited antitumor activity with IC50 values in the micro to nano molar range.
查看更多